Form 8-K - Current report:
SEC Accession No. 0001490978-24-000078
Filing Date
2024-09-12
Accepted
2024-09-12 16:32:08
Documents
14
Period of Report
2024-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-20240911.htm   iXBRL 8-K 37629
2 EX-10.1 ex101_schrodingercolumbiam.htm EX-10.1 497277
  Complete submission text file 0001490978-24-000078.txt   735584

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20240911.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20240911_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20240911_pre.xml EX-101.PRE 13054
17 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20240911_htm.xml XML 3223
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 241295361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)